As of December 2024, Apex Biotechnology has a market cap of $84.64M. This makes Apex Biotechnology the world's 21098th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $104.18M | -16.00% |
2023 | $124.03M | 57.73% |
2022 | $78.63M | -1.73% |
2021 | $80.02M | 9.70% |
2020 | $72.94M | -16.40% |
2019 | $87.25M | -4.55% |
2018 | $91.41M | -6.90% |
2017 | $98.18M | -22.76% |
2016 | $127.11M | -12.13% |
2015 | $144.65M | -19.52% |
2014 | $179.74M | -14.12% |
2013 | $209.28M | -9.33% |
2012 | $230.82M | 24.56% |
2011 | $185.31M | -11.95% |
2010 | $210.47M | 7.36% |
2009 | $196.05M | 53.90% |
2008 | $127.39M | -34.14% |
2007 | $193.42M | 85.03% |
2006 | $104.53M | 79.00% |
2005 | $58.40M | 14.22% |
2004 | $51.13M | -37.86% |
2003 | $82.28M | -10.68% |
2002 | $92.11M | -28.61% |
2001 | $129.03M | 3.29% |
2000 | $124.91M | - |